Related Experiment Video
Updated: Sep 12, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Androgen resistance due to mutation of the androgen receptor
Abstract:
The androgen receptor (AR) is a 'one-stop' signal transduction system that is the core of the intracellular androgen-response apparatus. It is an androgen-regulated, DNA-binding protein that regulates the expression of certain target genes, primarily at the transcriptional level. Mutations at the X-linked AR locus cause deficient or defective AR activity and, thereby, an extraordinarily wide spectrum of clinical androgen resistance. At one extreme, the affected 46,XY person is an infertile phenotypic female; at the other, he is a phenotypic male who may even be fertile, yet have gynecomastia or other focal signs of postpubertal subvirilization. We have identified 32 proven or putatively pathogenic alterations in the AR gene of 38 androgen-resistant families. This permits heterozygote detection and prenatal diagnosis whenever relevant. Most of the mutations affect the AR's androgen-binding domain, partly because our search has been targetted on those whose genital skin fibroblasts have impaired androgen-binding activities. The AR is a prototypic member of a subfamily that includes the receptors for progesterone, glucocorticoid, and mineralocorticoid. Observations that correlate AR genotype with clinical and receptor phenotypes of androgen resistance will help to generate a fine structure-function map of the AR and its close relatives. Constitutional variation in androgen sensitivity, that may be restricted to an organ (or organ system), could contribute to the pathogenesis of certain diseases whose sex ratio departs significantly from one.
Insights
Mutations in the androgen receptor (AR) gene cause a wide range of androgen resistance conditions. Identifying these AR gene alterations aids in diagnosis and understanding AR
Area of Science:
- Molecular endocrinology
- Genetics
- Human physiology
Background:
- The androgen receptor (AR) is a key DNA-binding protein regulating gene expression in response to androgens.
- Mutations in the AR gene lead to a spectrum of androgen resistance disorders, affecting sexual development and reproductive health.
- Understanding AR function is crucial for diagnosing and managing conditions related to androgen insensitivity.
Purpose of the Study:
- To identify pathogenic alterations in the androgen receptor (AR) gene in families with androgen resistance.
- To correlate AR genotype with clinical phenotypes and receptor activity in patients.
- To contribute to a structure-function map of the AR and related steroid receptors.
Main Methods:
- Genetic analysis of the AR gene in 38 families with androgen resistance.
- Assessment of androgen-binding activity in genital skin fibroblasts.
- Correlation of identified AR gene mutations with clinical presentation and receptor phenotypes.
Main Results:
- Identified 32 pathogenic or putatively pathogenic alterations in the AR gene across 38 families.
- Most identified mutations were located within the AR's androgen-binding domain.
- Findings enable heterozygote detection and prenatal diagnosis for relevant family members.
Conclusions:
- Genetic variations in the androgen receptor (AR) gene are a primary cause of androgen resistance.
- Detailed genotype-phenotype correlations enhance understanding of AR function and its role in disease.
- This research facilitates improved diagnostic capabilities and genetic counseling for androgen resistance disorders.
More Related Videos
Related Concept Videos
Mismatch Repair
Gene Conversion
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Treatment Resistant Cancers
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

